Join / Renew
Donate
Member Connect
Store
About A.S.P.E.N.
Membership
A.S.P.E.N. Career Center
Log in to my Aspen
Menu
Public Policy
Public Policy Home
Public Policy Agenda
How to Take Action
Public Policy Resources
Public Policy Awards
Continuing Education
ASPEN Nutrition Science & Practice Conference
Certification
Claim CE Credits
eLearning Center
LIFT-ECHO
Podcasts
Professional Development
Webinars
Calendar of Events
Guidelines & Clinical Resources
COVID-19 Resources
Books
Bookstore
International Orders
Book Catalog
eBook Center
eBooks for Groups
Classroom Discount Program
Clinical Practice Library
Clinical Guidelines
Consensus Recommendations
Standards
Journals
Malnutrition Solution Center
Malnutrition Awareness Week
Enteral Nutrition Resources
Parenteral Nutrition Resources
Resources for Patient Populations or Healthcare Management
Research
Abstracts
ASPEN Research Agenda
ASPEN Rhoads Research Foundation
Donors List
ASPEN Rhoads Research Foundation Board of Directors
Ways to Give
Success by the Numbers
Grant Recipients
Apply For Foundation Grants
Contact Us
EFFORT Trial
Research Awards
Research Toolkit
Membership
Join/Renew
Awards
ASPEN Chapters
ASPEN Sections
Member Spotlight
Physician Community
International Member Community
Corporate Scientific Advisory Council
Volunteer
About ASPEN
ASPEN Mission
About Clinical Nutrition
Our History
ASPEN Board of Directors
ASPEN Staff
Career Center
Jobs at ASPEN
Advertising & Sponsorship
Join / Renew
Donate
Member Connect
Store
General News
Product Shortage News
Public Policy News
All News
General News
Product Shortage News
Public Policy News
All News
Fresenius Kabi Letter Regarding Intralipid
Fresenius Kabi has provided
this letter
to reiterate its commitment to the short and long-term availability of Intralipid.